Product Information
ISONIAZID 300 MG TABLET is a generic product labeled by Genus Lifesciences Inc., priced at $3.4133 per EA under NDC 64950021710. Its NADAC has been published 63 times since Jan 1, 2025.
Strength
300 mg/1
Manufacturer
Genus Lifesciences Inc.NDC
64950021710
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ISONIAZIDApproval Type
Generic (ANDA)
FDA Application
ANDA080937On Market Since
11/1/2024
Pharmacological Classes
Price Statistics
The NADAC for ISONIAZID 300 MG TABLET has been published 63 times since Jan 1, 2025, and over the history we have for it it has risen 1438.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.4133 per EA |
|---|---|
| All-time high | $3.4133 (Jun 24, 2026) |
| All-time low | $0.2216 (Jan 22, 2025) |
| 52-week high | $3.4133 |
| 52-week low | $2.6149 |
| Median price | $3.1282 |
| Average price | $2.8602 |
| Largest weekly change | +1311.5% (May 21, 2025) |
| Weeks tracked | 63 |
| Tracking since | Jan 1, 2025 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ISONIAZID 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ISONIAZID 300 MG TABLET, manufactured by Genus Lifesciences Inc., is $3.4133 per EA (NDC 64950021710), effective Jun 24, 2026.
How has the price of ISONIAZID 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for ISONIAZID 300 MG TABLET has risen 1438.0%. It has been tracked across 63 weekly CMS publications since Jan 1, 2025.
What are the highest and lowest recorded NADAC prices for ISONIAZID 300 MG TABLET?
Since Jan 1, 2025, the NADAC for ISONIAZID 300 MG TABLET has ranged from a low of $0.2216 (Jan 22, 2025) to a high of $3.4133 (Jun 24, 2026), with a median of $3.1282 per EA.
Are there cheaper alternatives to ISONIAZID 300 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as ISONIAZID 300 MG TABLET, but none are currently priced below it.
Who manufactures ISONIAZID 300 MG TABLET?
ISONIAZID 300 MG TABLET (NDC 64950021710) is labeled by Genus Lifesciences Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification